ClinConnect ClinConnect Logo
Search / Trial NCT02051101

Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples

Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Jan 29, 2014

Trial Information

Current as of June 24, 2025

Completed

Keywords

ClinConnect Summary

The researcher can detect the defects in nervous system innervation to cutaneous blood vessels contribute to the pathogenesis of Port Wine Stain . Unveiling the pathogenic mechanisms of PWS is crucial to the design of new therapeutic strategies and can use the results to improve current PWS therapeutic outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female of all ages.
  • Not pregnant.
  • Has diagnosis of port wine stain on the arms, legs, chest, bac.
  • Ability to understand and carry out subject instructions.
  • Subject willing to have skin biopsies on port wine stain and normal skin areas.
  • Exclusion Criteria:
  • Pregnant women.
  • Port Wine Stain on the face.
  • History of skin cancer.
  • Current participation in an investigational drug evaluation
  • Concurrent use of known photosensitizing drugs.

About University Of California, Irvine

The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.

Locations

Irvine, California, United States

Patients applied

0 patients applied

Trial Officials

John s Nelson, MD

Study Director

Beckman Laser Institute, UCI

Winbin Tan, PhD

Principal Investigator

Beckman Laser Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials